Sep 2026
Impact of Shexiang Baoxin Pill (MUSKARDIA) on Cardiovascular Outcomes by Baseline Hemoglobin Levels in 2,494 Patients with Chronic Stable Coronary Artery Disease: A Secondary Subgroup Analysis.
MUSKARDIA demonstrated significant cardiovascular protective effects in CAD patients with Hb < 140 g/L, particularly reducing non-fatal MI risk, while showing limited efficacy in patients with Hb>140 g/L, which highlights its cardiovascular protective role in high-risk populations characterized by greater ischemic risk...
Jing-Min Zhou, Hai-Ming Shi, Yang Wu et al.
· Chinese Journal of Integrati... · 0 citations